CellAxia Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $4.75M

  • Investors
  • 12

CellAxia General Information

Description

Operator of a biotechnology company intended to develop cell therapy drugs. The company is engaged in the discovery, development and commercialization of biological therapies for the treatment of intractable autoimmune diseases, enabling researchers to use difficult-to-transect cells like primary and cancer stem cell cultures and discover new therapeutic cell-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 1-10-9 Nihonbashi Horidome-cho, Chuo-ku
  • Logs Nihonbashi Horidome Building 6th Floor
  • Tokyo, Chuo-ku 103-0012
  • Japan
+81 00-0000-0000

CellAxia Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellAxia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 19-Aug-2022 $4.75M 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 11-Sep-2020 00.000 000.00 000.00 Completed Generating Revenue
1. Seed Round 28-Jan-2019 $3.85M $3.85M 000.00 Completed Generating Revenue
To view CellAxia’s complete valuation and funding history, request access »

CellAxia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class C preferred 0,000 00000.00 00000.00 00 00000.00 00.000
Class B Preferred 0,000 0000.00 0000.00 00 0000.00 00.000
Class A Preferred 5,250 $594.2 $594.2 1x $594.2 15.78%
To view CellAxia’s complete cap table history, request access »

CellAxia Patents

CellAxia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220298486-A1 Urothelial cell induction agent and method for inducing urothelial cells Pending 30-Aug-2019 0000000000
EP-4023248-A1 Urothelial cell induction agent and method for inducing urothelial cells Pending 30-Aug-2019 0000000000
EP-4023248-A4 Urothelial cell induction agent and method for inducing urothelial cells Pending 30-Aug-2019 000000000 0
US-20220218744-A1 Cell-containing pharmaceutical composition Pending 19-Aug-2019 000000000
JP-7500083-B2 Cell-containing pharmaceutical composition Active 19-Aug-2019 0
To view CellAxia’s complete patent history, request access »

CellAxia Executive Team (1)

Name Title Board Seat Contact Info
Makoto Seki Founder, Chief Executive Officer & President
To view CellAxia’s complete executive team members history, request access »

CellAxia Board Members (3)

Name Representing Role Since
Hiroyuki Misawa Ph.D Miyako Capital Board Member 000 0000
Shuichiro Kadowaki Ph.D CellAxia Board Member 000 0000
Tadashi Hishida CellAxia Audit & Supervisory Board Member 000 0000
To view CellAxia’s complete board members history, request access »

CellAxia Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Green Core Co., Ltd Corporation Minority 000 0000 000000 0
AJ Capital (Japan) Venture Capital Minority 000 0000 000000 0
FFG Venture Business Partners Corporate Venture Capital Minority 000 0000 000000 0
Japan Asia Investment PE/Buyout Minority 000 0000 000000 0
Kyoto Bank Lease Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

CellAxia FAQs

  • When was CellAxia founded?

    CellAxia was founded in 2017.

  • Who is the founder of CellAxia?

    Makoto Seki is the founder of CellAxia.

  • Who is the CEO of CellAxia?

    Makoto Seki is the CEO of CellAxia.

  • Where is CellAxia headquartered?

    CellAxia is headquartered in Tokyo, Japan.

  • What industry is CellAxia in?

    CellAxia’s primary industry is Drug Discovery.

  • Is CellAxia a private or public company?

    CellAxia is a Private company.

  • What is the current valuation of CellAxia?

    The current valuation of CellAxia is 000.00.

  • What is CellAxia’s current revenue?

    The current revenue for CellAxia is 00000.

  • How much funding has CellAxia raised over time?

    CellAxia has raised $15.7M.

  • Who are CellAxia’s investors?

    Green Core Co., Ltd, AJ Capital (Japan), FFG Venture Business Partners, Japan Asia Investment, and Kyoto Bank Lease Capital are 5 of 12 investors who have invested in CellAxia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »